Salmonella engages host MicroRNAs to modulate SUMOylation: A new arsenal for intracellular survival

Molecular and Cellular Biology

Volumn 35, Issue 17, 2015, Pages 2932-2946

  Verma, Smriti ^a   Mohapatra, Gayatree ^a,c   Ahmad, Salman Mustfa ^a,c   Rana, Sarika ^a   Jain, Swati ^a   Khalsa, Jasneet Kaur ^b   Srikanth, C V ^a  

^a REGIONAL CENTRE FOR BIOTECHNOLOGY   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c MANIPAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; MICRORNA; PROTEOME; SMALL UNTRANSLATED RNA; SUMO PROTEIN; MIRN30D MICRORNA, MOUSE; PIAS1 PROTEIN, MOUSE; PROTEIN INHIBITOR OF ACTIVATED STAT; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN-CONJUGATING ENZYME UBC9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HOST; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PROCESSING; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SUMOYLATION; UPREGULATION; ANIMAL; C57BL MOUSE; GENETICS; HELA CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PATHOGENICITY; PATHOLOGY; TUMOR CELL LINE;

SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

ANIMALS; CELL LINE, TUMOR; FEMALE; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, INBRED C57BL; MICRORNAS; PROTEIN INHIBITORS OF ACTIVATED STAT; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SUMOYLATION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84938843203     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00397-15     Document Type: Article

References (50)

1. Zhang Y, Higashide WM, McCormick BA, Chen J, Zhou D. 2006. The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase. Mol Microbiol 62:786-793. http://dx.doi.org/10.1111/j.1365-2958.2006.05407.x.
2. Ribet D, Cossart P. 2010. Pathogen-mediated posttranslational modifications: a re-emerging field. Cell 143:694-702. http://dx.doi.org/10.1016/j.cell.2010.11.019.
3. Desterro JM, Rodriguez MS, Hay RT. 1998. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2:233-239. http://dx.doi.org/10.1016/S1097-2765(00)80133-1.
4. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A. 2000. c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 275:13321-13329. http://dx.doi.org/10.1074/jbc.275.18.13321.
5. Flotho A, Melchior F. 2013. Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem 82:357-385. http://dx.doi.org/10.1146/annurev-biochem-061909-093311.
6. Kim JG, Stork W, Mudgett MB. 2013. Xanthomonas type III effector XopD desumoylates tomato transcription factor SlERF4 to suppress ethylene responses and promote pathogen growth. Cell Host Microbe 13:143-154. http://dx.doi.org/10.1016/j.chom.2013.01.006.
7. Chang TH, Kubota T, Matsuoka M, Jones S, Bradfute SB, Bray M, Ozato K. 2009. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog 5:e1000493. http://dx.doi.org/10.1371/journal.ppat.1000493.
8. Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, Neyret-Kahn H, Gevaert K, Vandekerckhove J, Dejean A, Cossart P. 2010. Listeria monocytogenes impairs SUMOylation for efficient infection. Nature 464:1192-1195. http://dx.doi.org/10.1038/nature08963.
9. Fritah S, Lhocine N, Golebiowski F, Mounier J, Andrieux A, Jouvion G, Hay RT, Sansonetti P, Dejean A. 2014. Sumoylation controls host anti-bacterial response to the gut invasive pathogen Shigella flexneri. EMBO Rep 15:965-972. http://dx.doi.org/10.15252/embr.201338386.
10. Dunphy PS, Luo T, McBride JW. 2014. Ehrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival. Infect Immun 82:4154-4168. http://dx.doi.org/10.1128/IAI.01984-14.
11. Beyer AR, Truchan HK, May LJ, Walker NJ, Borjesson DL, Carlyon JA. 2015. The Anaplasma phagocytophilum effector AmpA hijacks host cell SUMOylation. Cell Microbiol 17:504-519. http://dx.doi.org/10.1111/cmi.12380.
12. Zhang YG, Wu S, Xia Y, Chen D, Petrof EO, Claud EC, Hsu W, Sun J. 2012. Axin1 prevents Salmonella invasiveness and inflammatory response in intestinal epithelial cells. PLoS One 7:e34942. http://dx.doi.org/10.1371/journal.pone.0034942.
13. Srikanth CV, Cherayil BJ. 2007. Intestinal innate immunity and the pathogenesis of Salmonella enteritis. Immunol Res 37:61-78. http://dx.doi.org/10.1007/BF02686090.
14. Haraga A, Ohlson MB, Miller SI. 2008. Salmonellae interplay with host cells. Nat Rev Microbiol 6:53-66. http://dx.doi.org/10.1038/nrmicro1788.
15. Hansen-Wester I, Hensel M. 2001. Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect 3:549-559. http://dx.doi.org/10.1016/S1286-4579(01)01411-3.
16. Kubori T, Matsushima Y, Nakamura D, Uralil J, Lara-Tejero M, Sukhan A, Galan JE, Aizawa SI. 1998. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280:602-605. http://dx.doi.org/10.1126/science.280.5363.602.
17. Hueck CJ. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62:379-433.
18. Francis CL, Starnbach MN, Falkow S. 1992. Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions. Mol Microbiol 6:3077-3087. http://dx.doi.org/10.1111/j.1365-2958.1992.tb01765.x.
19. Hannemann S, Gao B, Galan JE. 2013. Salmonella modulation of host cell gene expression promotes its intracellular growth. PLoS Pathog 9:e1003668. http://dx.doi.org/10.1371/journal.ppat.1003668.
20. Chen LM, Hobbie S, Galan JE. 1996. Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 274:2115-2118. http://dx.doi.org/10.1126/science.274.5295.2115.
21. Patel JC, Galan JE. 2006. Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J Cell Biol 175:453-463. http://dx.doi.org/10.1083/jcb.200605144.
22. Carrol ME, Jackett PS, Aber VR, Lowrie DB. 1979. Phagolysosome formation, cyclic adenosine 3':5'-monophosphate and the fate of Salmonella typhimurium within mouse peritoneal macrophages. J Gen Microbiol 110:421-429. http://dx.doi.org/10.1099/00221287-110-2-421.
23. Drecktrah D, Knodler LA, Howe D, Steele-Mortimer O. 2007. Salmonella trafficking is defined by continuous dynamic interactions with the endolysosomal system. Traffic 8:212-225. http://dx.doi.org/10.1111/j.1600-0854.2006.00529.x.
24. Ruiz-Albert J, Yu XJ, Beuzon CR, Blakey AN, Galyov EE, Holden DW. 2002. Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane. Mol Microbiol 44:645-661. http://dx.doi.org/10.1046/j.1365-2958.2002.02912.x.
25. Ayaydin F, Dasso M. 2004. Distinct in vivo dynamics of vertebrateSUMO paralogues. Mol Biol Cell 15:5208-5218. http://dx.doi.org/10.1091/mbc.E04-07-0589.
26. Bekes M, Prudden J, Srikumar T, Raught B, Boddy MN, Salvesen GS. 2011. The dynamics and mechanism of SUMO chain deconjugation by SUMO-specific proteases. J Biol Chem 286:10238-10247. http://dx.doi.org/10.1074/jbc.M110.205153.
27. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Russmann H, Hardt WD. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71:2839-2858. http://dx.doi.org/10.1128/IAI.71.5.2839-2858.2003.
28. Pott J, Stockinger S, Torow N, Smoczek A, Lindner C, McInerney G, Backhed F, Baumann U, Pabst O, Bleich A, Hornef MW. 2012. Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog 8:e1002670. http://dx.doi.org/10.1371/journal.ppat.1002670.
29. Srikanth CV, Wall DM, Maldonado-Contreras A, Shi HN, Zhou D, Demma Z, Mumy KL, McCormick BA. 2010. Salmonella pathogenesis and processing of secreted effectors by caspase-3. Science 330:390-393. http://dx.doi.org/10.1126/science.1194598.
30. Matunis MJ, Coutavas E, Blobel G. 1996. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135:1457-1470. http://dx.doi.org/10.1083/jcb.135.6.1457.
31. Hay RT. 2005. SUMO: a history of modification. Mol Cell 18:1-12. http://dx.doi.org/10.1016/j.molcel.2005.03.012.
32. Golebiowski F, Matic I, Tatham MH, Cole C, Yin Y, Nakamura A, Cox J, Barton GJ, Mann M, Hay RT. 2009. System-wide changes to SUMO modifications in response to heat shock. Sci Signal 2:ra24. http://dx.doi.org/10.1126/scisignal.2000282.
33. Garcia-del Portillo F, Finlay BB. 1995. Targeting of Salmonella typhimurium to vesicles containing lysosomal membrane glycoproteins bypasses compartments with mannose 6-phosphate receptors. J Cell Biol 129:81-97. http://dx.doi.org/10.1083/jcb.129.1.81.
34. Jackson LK, Nawabi P, Hentea C, Roark EA, Haldar K. 2008. The Salmonella virulence protein SifA is aGprotein antagonist. Proc Natl Acad SciUSA 105:14141-14146. http://dx.doi.org/10.1073/pnas.0801872105.
35. Liu B, Shuai K. 2008. Targeting the PIAS1 SUMO ligase pathway to control inflammation. Trends Pharmacol Sci 29:505-509. http://dx.doi.org/10.1016/j.tips.2008.07.008.
36. Zhao Z, Tan X, Zhao A, Zhu L, Yin B, Yuan J, Qiang B, Peng X. 2012. microRNA-214-mediated UBC9 expression in glioma. BMB Rep 45:641-646. http://dx.doi.org/10.5483/BMBRep.2012.45.11.097.
37. Wu F, Zhu S, Ding Y, Beck WT, Mo YY. 2009. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res 15:1550-1557. http://dx.doi.org/10.1158/1078-0432.CCR-08-0820.
38. Patel JC, Hueffer K, Lam TT, Galan JE. 2009. Diversification of a Salmonella virulence protein function by ubiquitin-dependent differential localization. Cell 137:283-294. http://dx.doi.org/10.1016/j.cell.2009.01.056.
39. Adamson AL, Kenney S. 2001. Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75:2388-2399. http://dx.doi.org/10.1128/JVI.75.5.2388-2399.2001.
40. Parkinson J, Everett RD. 2000. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J Virol 74:10006-10017. http://dx.doi.org/10.1128/JVI.74.21.10006-10017.2000.
41. Boggio R, Colombo R, Hay RT, Draetta GF, Chiocca S. 2004. A mechanism for inhibiting the SUMO pathway. Mol Cell 16:549-561. http://dx.doi.org/10.1016/j.molcel.2004.11.007.
42. Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, Mangel WF, Staskawicz B, Dixon JE. 2000. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290:1594-1597. http://dx.doi.org/10.1126/science.290.5496.1594.
43. Tattoli I, Sorbara MT, Vuckovic D, Ling A, Soares F, Carneiro LA, Yang C, Emili A, Philpott DJ, Girardin SE. 2012. Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program. Cell Host Microbe 11:563-575. http://dx.doi.org/10.1016/j.chom.2012.04.012.
44. Liu LB, Omata W, Kojima I, Shibata H. 2007. The SUMO conjugating enzyme Ubc9 is a regulator of GLUT4 turnover and targeting to the insulin-responsive storage compartment in 3T3-L1 adipocytes. Diabetes 56:1977-1985. http://dx.doi.org/10.2337/db06-1100.
45. Kurihara I, Shibata H, Kobayashi S, Suda N, Ikeda Y, Yokota K, Murai A, Saito I, Rainey WE, Saruta T. 2005. Ubc9 and protein inhibitor of activated STAT 1 activate chicken ovalbumin upstream promoter-transcription factor I-mediated human CYP11B2 gene transcription. J Biol Chem 280:6721-6730. http://dx.doi.org/10.1074/jbc.M411820200.
46. Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY. 2010. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene 29:1763-1772. http://dx.doi.org/10.1038/onc.2009.459.
47. Uemura A, Taniguchi M, Matsuo Y, Oku M, Wakabayashi S, Yoshida H. 2013. UBC9 regulates the stability of XBP1, a key transcription factor controlling the ER stress response. Cell Struct Funct 38:67-79.
48. Schulte LN, Eulalio A, Mollenkopf HJ, Reinhardt R, Vogel J. 2011. Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. EMBO J 30:1977-1989. http://dx.doi.org/10.1038/emboj.2011.94.
49. Gu H, Zhang T, Li D, Liu F, Zhang CY, Zen K. 2014. A Salmonellaencoded microRNA-like RNA facilitates bacterial invasion and intracellular replication via suppressing host cell inducible nitric oxide synthase (MPF3P.809). J Immunol 192:132.
50. Maudet C, Mano M, Sunkavalli U, Sharan M, Giacca M, Forstner KU, Eulalio A. 2014. Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection. Nat Commun 5:4718. http://dx.doi.org/10.1038/ncomms5718.